Qana
  • Home
  • landing
    • news
  • Company news
Select Page

Qana closes new funding from leading mid-continent seed stage investor

by admin | Aug 25, 2023 | Company news

Proprietary delivery platform, based on endogenous human cholesterol transport, offers the potential to enable novel medicines across a broad range of modalities and therapeutic areas. New funding raised from life sciences investor Research Bridge Partners. AUSTIN,...

Recent Posts

  • Qana Leadership Travels to Boston for I-Corps Kickoff
  • Qana presents at San Antonio’s BioFest Invest 2024
  • Qana Therapeutics receives NIH (NCI) Innovative Concept Award to advance a novel therapeutic for adrenocortical carcinoma
  • Qana closes new funding from leading mid-continent seed stage investor
  • Rutledge Cancer Foundation invests in Qana Therapeutics’s Ewing sarcoma program

Recent Comments

    Archives

    • July 2024
    • April 2024
    • August 2023
    • May 2023

    Categories

    • Company news

    Team

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    © Copyright 2025. Qana Therapeutics Inc. All Rights Reserved.